Navigation Links
Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
Date:5/17/2013

2 clinical trials under an Investigational New Drug application with the U.S. Food and Drug Administration, and with its oral exenatide capsule (ORMD-0901; a GLP-1 analog), currently approaching Phase 2a trials. The company's corporate and R&D headquarters are based in Jerusalem.

For more information, the content of which is not part of this press release, please visit  http://www.oramed.com

Forward-looking statements: This press release contains forward-looking statements. For example, we are using forward-looking statements when we discuss ORMD-0801 slowing the rate of diabetes, increasing patient compliance, and our products approaching Phase 2 trials. These forward-looking statements are based on the current expectations of the management of Oramed only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval or patent protection for our product candidates; competition from other pharmaceutical or biotechnology companies; and our ability to obtain additional funding required to conduct our research, development and commercialization activities. In addition, the following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; delays or obstacles in launching our clinical trials; changes in legislation; inability to timely develop and introduce new technologies, products and applications; lack of validation of our technology as we progress further and lack of acceptance of our methods by the scientific community; inability to retain or attract key employe
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012
2. Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
3. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
4. Oramed Pharmaceuticals Completes $5.6 Million Funding to Advance Clinical Trials
5. Oramed Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th
6. Shares of Oramed Pharmaceuticals Are Approved for Listing on the Nasdaq Capital Market
7. Oramed Pharmaceuticals to Present at the 4th Annual Drug Delivery & Formulation Summit in Berlin
8. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
9. Oramed Submits New IND Application for Oral Insulin Trial in the US
10. Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development
11. Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014  TNI BioTech, Inc. (OTCQB: TNIB) ... on the development, marketing and distribution of opioid-related ... proxy materials with the Securities and Exchange Commission ... Shareholders to be held on Thursday, September 4, ... record date for determining those shareholders eligible to ...
(Date:7/28/2014)... , 28 luglio 2014 ResMed (NYSE: ... di prodotti per la cura dei disturbi respiratori del ... ha avuto un,ingiunzione permanente in Germania contro il produttore ... proibisce la vendita di apparecchiature da indossare in testa, ... e le maschere 220. La sentenza della Corte Regionale ...
(Date:7/28/2014)... 28, 2014  ResMed (NYSE: RMD ), ... treatment of sleep-disordered breathing and other chronic respiratory conditions, ... against Taiwanese medical device manufacturer APEX Medical ... APEX WiZARD 210 and 220 masks.  The judgment was ... Munich , is appealable, and applies throughout Germany.  ...
Breaking Medicine Technology:TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2
... Acuo Technologies®, a market leading provider of ... for archiving, collaboration and migration services, announces another ... The company achieved 25% growth over the previous ... growth rate of 55% in revenue, while adding ...
... Today, Siemens (NYSE: SI ) announces ... Medical Informatics Officer (CMIO), of the Health Services (HS) Business ... Health Information Exchange (IHIE), Marc recently served as ... role at Siemens, Marc will be responsible for clinical informatics ...
Cached Medicine Technology:Acuo Technologies Announces Another Significant Growth Year in Revenue and Implementations to Further the Company's Market Leading Position 2Siemens Appoints Overhage as New Chief Medical Informatics Officer 2
(Date:7/28/2014)... divide unless there is enough oxygen present to support ... types circumvent this rule. Researchers at The Johns Hopkins ... cells, warning signals, enabling cancers to continue to divide ... the researchers found that lysosomes the cell,s protein ... also uncovered new evidence that certain drugs can halt ...
(Date:7/28/2014)... Parker Waichman LLP, a personal injury law firm ... heroes of 9/11 are never forgotten, comments that the September ... According to a VCF message dated July 3, ... or before October 12, 2012 must file a Registration Form ... who were allegedly injured by the toxic dust cloud that ...
(Date:7/28/2014)... York, NY (PRWEB) July 28, 2014 ... literacy organization that has donated more than 200,000 books ... in 2001, announces the launch of Brooke’s Cooks, a ... values, while encouraging healthy living among at-risk children and ... Cooks will include a series of nutrition information workshops, ...
(Date:7/28/2014)... Utah (PRWEB) July 28, 2014 Bariatric ... and drinks, announced that it will be introducing three ... of products this summer. The additional flavors include: , ... pure taste-free protein , Inspire Pomegranate Razz Berry -­ ... flavor of soft-serve vanilla cone , Bariatric Eating's ...
(Date:7/28/2014)... one of two dopamine-producing regions in the brain was ... isoflurane or propofol. In the August issue of ... report that rats anesthetized with continuous doses of either ... up in response to electrical stimulation delivered to the ... major dopamine-releasing area, the substantia nigra, did not induce ...
Breaking Medicine News(10 mins):Health News:Cell's recycling center implicated in division decisions 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 2Health News:October 12, 2014 Deadline Approaching for 9/11 First Responders Suffering from Certain Cancers to Submit Their Registration to the VCF, Parker Waichman LLP Comments 3Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 2Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 3Health News:Brooke Jackman Foundation Launches Brooke's Cooks, New Initiative to Promote Healthy Living Among At-Risk Youth and Their Families 4Health News:Bariatric Eating Announces Three New Protein Shake Flavors 2Health News:Stimulation of brain region restores consciousness to animals under general anesthesia 2
... To Conduct Conference Call Today at 11am ET - SOMERSET, ... TSTF ), a national provider of healthcare and administrative ... quarter ended March 31, 2009. TeamStaff,s operating revenues for the ... compared to $16.1 million in the comparable quarter last year. ...
... Recurring Revenues Climb 84%; Free Cash Flow ... Med Technologies(R), Inc. ("Global Med" or the ... healthcare information technology company, today reported profitability ... growth for the first quarter ended March ...
... BioMarin,s Efforts to Expand Treatment Options for Patients with ... BMRN ) announced today that it has ... for Rare Disorders (NORD), an organization dedicated to improving ... was presented on May 14 at NORD,s annual "Partners ...
... help control anxiety, experts say, , , FRIDAY, May 15 (HealthDay ... isn,t something associated with heights, a job interview or getting ... of worry and tension that affects twice as many women ... eroding their quality of life. , But a new study ...
... study shows CMV raises risk of hypertension, hardening of arteries ... infection that most adults harbor could be a cause of ... cytomegalovirus (CMV) were more likely to develop not only high ... atherosclerosis, according to a report in the May 15 issue ...
... The following news tips are based on abstracts or posters ... Society of Clinical Oncology (ASCO) in Orlando, Florida, May 29 ... 8 a.m. to noon on Monday, June 1, 2009, Antiparasitic ... , Seth J. Orlow, M.D., Ph.D., the Samuel Weinberg ...
Cached Medicine News:Health News:TeamStaff Reports Second Quarter Results 2Health News:TeamStaff Reports Second Quarter Results 3Health News:TeamStaff Reports Second Quarter Results 4Health News:TeamStaff Reports Second Quarter Results 5Health News:TeamStaff Reports Second Quarter Results 6Health News:TeamStaff Reports Second Quarter Results 7Health News:TeamStaff Reports Second Quarter Results 8Health News:TeamStaff Reports Second Quarter Results 9Health News:TeamStaff Reports Second Quarter Results 10Health News:TeamStaff Reports Second Quarter Results 11Health News:TeamStaff Reports Second Quarter Results 12Health News:TeamStaff Reports Second Quarter Results 13Health News:TeamStaff Reports Second Quarter Results 14Health News:TeamStaff Reports Second Quarter Results 15Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 2Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 3Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 4Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 5Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 6Health News:BioMarin Receives 2009 Corporate Award for the Development of Kuvan 2Health News:BioMarin Receives 2009 Corporate Award for the Development of Kuvan 3Health News:BioMarin Receives 2009 Corporate Award for the Development of Kuvan 4Health News:Fear Response May Stem From Protein in Brain 2Health News:Viral Infection Might Trigger High Blood Pressure 2Health News:Viral Infection Might Trigger High Blood Pressure 3Health News:NYU Langone Medical Center's tip sheet to the 45th Annual Meeting of ASCO 2Health News:NYU Langone Medical Center's tip sheet to the 45th Annual Meeting of ASCO 3Health News:NYU Langone Medical Center's tip sheet to the 45th Annual Meeting of ASCO 4
Transcranial vascular DWL doppler....
Transcranil vascular DWL doppler....
... is a powerful automated system capable of ... from 6 user-programmable test protocols to begin ... Any tests not included in the comprehensive ... handled using the Doppler, PVR and PPG ...
The CD Horizon M10 Spinal System provide spine surgeons comprehensive solutions for the treatment of spinal deformities, trauma reconstruction, and degenerative conditions....
Medicine Products: